Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS: OTLC · Delayed Price · USD
0.0394
-0.0026 (-6.19%)
Apr 19, 2024, 3:35 PM EDT - Market closed

Oncotelic Therapeutics Statistics

Total Valuation

OTLC has a market cap or net worth of $15.75 million. The enterprise value is $29.59 million.

Market Cap 15.75M
Enterprise Value 29.59M

Important Dates

The last earnings date was Thursday, April 13, 2023.

Earnings Date Apr 13, 2023
Ex-Dividend Date n/a

Share Statistics

OTLC has 399.68 million shares outstanding. The number of shares has increased by 1.87% in one year.

Shares Outstanding 399.68M
Shares Change (YoY) +1.87%
Shares Change (QoQ) +0.35%
Owned by Insiders (%) 54.83%
Owned by Institutions (%) n/a
Float 180.54M

Valuation Ratios

PE Ratio n/a
Forward PE 4.03
PS Ratio 239.81
Forward PS n/a
PB Ratio 1.38
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 422.76
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.02, with a Debt / Equity ratio of 1.07.

Current Ratio 0.02
Quick Ratio 0.01
Debt / Equity 1.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -0.63

Financial Efficiency

Return on equity (ROE) is -71.22% and return on invested capital (ROIC) is -26.60%.

Return on Equity (ROE) -71.22%
Return on Assets (ROA) -28.78%
Return on Capital (ROIC) -26.60%
Revenue Per Employee $3,182
Profits Per Employee -$392,695
Employee Count 22
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax -5.39M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.20% in the last 52 weeks. The beta is 0.06, so OTLC's price volatility has been lower than the market average.

Beta (1Y) 0.06
52-Week Price Change -20.20%
50-Day Moving Average 0.04
200-Day Moving Average 0.03
Relative Strength Index (RSI) 49.68
Average Volume (30 Days) 78,274

Short Selling Information

The latest short interest is 662,753, so 0.17% of the outstanding shares have been sold short.

Short Interest 662,753
Short Previous Month 812,771
Short % of Shares Out 0.17%
Short % of Float 0.37%
Short Ratio (days to cover) 8.04

Income Statement

In the last 12 months, OTLC had revenue of $70,000 and -$8.64 million in losses. Loss per share was -$0.02.

Revenue 70,000
Gross Profit 70,000
Operating Income -6.69M
Pretax Income -8.21M
Net Income -8.64M
EBITDA -492,622
EBIT -659,056
Loss Per Share -$0.02
Full Income Statement

Balance Sheet

The company has $190,405 in cash and $13.00 million in debt, giving a net cash position of -$12.81 million or -$0.03 per share.

Cash & Cash Equivalents 190,405
Total Debt 13.00M
Net Cash -12.81M
Net Cash Per Share -$0.03
Equity / Book Value 12.13M
Book Value Per Share 0.03
Working Capital -16.23M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.32M
Capital Expenditures n/a
Free Cash Flow -1.32M
FCF Per Share -$0.00
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -9,550.00% and -12,341.86%.

Gross Margin 100.00%
Operating Margin -9,550.00%
Pretax Margin -11,722.95%
Profit Margin -12,341.86%
EBITDA Margin -703.75%
EBIT Margin -941.51%
FCF Margin -1,887.21%

Dividends & Yields

OTLC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.87%
Shareholder Yield -1.87%
Earnings Yield -51.47%
FCF Yield -7.87%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on December 28, 2012. It was a reverse split with a ratio of 1:12.

Last Split Date Dec 28, 2012
Split Type Reverse
Split Ratio 1:12

Scores

OTLC has an Altman Z-Score of -1.74 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.74
Piotroski F-Score 1